Pharmaceutical Fill and Finish Outsourcing Market Forecast to 2028 The rising demand from pharmaceutical and biopharmaceutical industries to meet the demand for fill/finish gap is expected to drive the market growth. According to the US Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER), biologics have accounted for 20% to 29% of approvals of new molecular entities (NMEs) in 2020. In 2019, small molecules...
0 Μοιράστηκε
1059 Views
0 Προεπισκόπηση